Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs

Autor: Alexander Gerbaulet, Rayk Behrendt, Benjamin Gabriel, Martin Kleefisch, Min Ae Lee-Kirsch, Axel Roers, Martin Achleitner, Uwe Fiebig, Anastasia Polikarpova, Reinhard Oertel, Alexander Hennig, Livia Schulze, Katrin Peschke, Dirk Lindeman
Rok vydání: 2017
Předmět:
Zdroj: The Journal of Immunology. 199:2261-2269
ISSN: 1550-6606
0022-1767
DOI: 10.4049/jimmunol.1700714
Popis: Biallelic mutations of three prime repair exonuclease 1 (TREX1) cause the lupus-like disease Aicardi–Goutières syndrome in which accumulation of a yet unknown endogenous DNA substrate of TREX1 triggers a cyclic GMP–AMP synthase-dependent type I IFN response and systemic autoimmunity. Products of reverse transcription originating from endogenous retroelements have been suggested to be a major substrate for TREX1, and reverse transcriptase inhibitors (RTIs) were proposed as a therapeutic option in autoimmunity ensuing from defects of TREX1. In this study, we treated Trex1−/− mice with RTIs. The serum RTI levels reached were sufficient to block retrotransposition of endogenous retroelements. However, the treatment did not reduce the spontaneous type I IFN response and did not ameliorate lethal inflammation. Furthermore, long interspersed nuclear elements 1 retrotransposition was not enhanced in the absence of Trex1. Our data do not support the concept of retroelement-derived cDNA as key triggers of systemic autoimmunity in Trex1-deficient humans and mice and motivate the continuing search for the pathogenic IFN-inducing Trex1 substrate.
Databáze: OpenAIRE